Skip to content

The clinical significance of serum caveolin-1 in binge drinking induced liver damage and its correlation with the drunken state

The clinical significance of serum caveolin-1 in binge drinking induced liver damage and its correlation with the drunden state

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003344
Enrollment
Unknown
Registered
2013-01-14
Start date
2013-06-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

binge drinking induced liver damage

Interventions

Experimental group:drink alcohol
parallel control group:drink water

Sponsors

Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
21 Years to 45 Years

Inclusion criteria

Inclusion criteria: Participants are 21-45 years adult male. Inclusion criteria:Body Weight is in the range of standard weight ± 10% [standard body weight (kg) = 0.7*(height cm-80)]; all tests of heart, liver, kidney, blood and others are in normal range; no history of alcohol dependence; ethanol consumption less than 140g per week over the last three months before the trial; no single-dose heavy drinking(defined as ethanol consumption more than 80g per day); no alcohol drinking during the last two weeks before the trial; no sickness or medication during the last one week before the trial; have already signed the informed consent of this project.

Exclusion criteria

Exclusion criteria: No drinking experience; who has already participated in other clinical trials in four weeks before the start of the project; Who has a allergy of alcohol food or other drugs; who has fainting history with the reason of low blood sugar or acupuncture syncope; who is easy to vomit after a little drinking(about 50ml liquor of 40 degrees); non-alcoholic fatty liver disease (fatty liver disease obese persons and spontaneous fatty liver); who is a mental or physical disability; who has a lower income group might nature (such as the infirm, etc.) based on investigator's judgment; gastrointestinal system diseases (such as acute and chronic gastritis, gastric ulcer and duodenal ulcer, etc.); cardiovascular disease (hypertension, hypotension, arrhythmia, atrial fibrillation, etc.); who has a history of liver diseases with viral infections (such as hepatitis B, hepatitis C); respiratory system diseases (eg, pneumonia, asthma).

Design outcomes

Primary

MeasureTime frame
The expression of caveolin-1 in serum;Liver function tests;blood lipid tests;Blood alcohol concentration;

Secondary

MeasureTime frame
Tempreture;Blood pressure;Heart rate;

Countries

China

Contacts

Public ContactLYU Zhiping
lzp48241@126.com+86 13802925633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026